What does InSilico Medicine Cayman TopCo do?

InSilico Medicine uses artificial intelligence to find new disease targets and design new drug molecules faster than traditional methods. It runs its own pipeline of drug candidates for conditions such as fibrosis, cancer, immune and metabolic diseases, and pain. It also licenses its AI software and partners with drugmakers to speed up their research.

Healthcare · Biotechnology · 3696.HK

What InSilico Medicine Cayman TopCo Does & How It Makes Money (3696.HK)

Updated October 2026 · reflects InSilico Medicine Cayman TopCo's latest reported financials

AI-driven biotech company discovering and developing new drugs. The company earns revenue from R&D collaborations and business development deals with pharma partners such as Takeda, from selling its Pharma.AI software solutions, and potentially from licensing its drug candidates.

InSilico Medicine Cayman TopCo's story, moat and numbers — in a 3-minute visual book.

Explore InSilico Medicine Cayman TopCo on TacticScale →

How InSilico Medicine Cayman TopCo makes money

The company earns revenue from R&D collaborations and business development deals with pharma partners such as Takeda, from selling its Pharma.AI software solutions, and potentially from licensing its drug candidates.

What InSilico Medicine Cayman TopCo does

InSilico Medicine, founded in 2014 and headquartered in the New Territories, Hong Kong, is a biotechnology company that applies AI across drug discovery and development. Its proprietary Pharma.AI platform covers identifying new targets, generating small molecules, and predicting clinical outcomes, and it supports an in-house pipeline spanning fibrosis, oncology, immunology, metabolic disease, pain and other areas. Beyond its own pipeline, the company earns money from R&D collaborations, software solutions and business development. Its partners include Takeda, which uses Pharma.AI to advance drug candidates; Suzhou Ribo Life Science, for oligonucleotide therapeutics; and Human Life Foundation Models, for longevity-science foundation models. It operates across Asia, the Middle East, Europe and the United States.

Products & services

Pharma.AI platform
AI target identification
AI small molecule generation
Clinical outcome prediction
Drug pipeline (fibrosis, oncology, immunology, metabolic, pain)

What is InSilico Medicine Cayman TopCo worth?

Fair value: not published

A reliable owner-earnings fair value isn't available for this company yet — we'd rather say so than print a number we don't trust.

We show a fair value only when the method is trustworthy. See InSilico Medicine Cayman TopCo on TacticScale →

Sector Healthcare Industry Biotechnology HQ Hong Kong Ticker 3696.HK Official site

Related companies

InventisBio (688382.SS) · Incyte (INCY)

Understand InSilico Medicine Cayman TopCo in 3 minutes →